logo
Plus   Neg
Share
Email

Thermo Fisher Reportedly Considers To Buy Diagnostics Firm Qiagen

Thermo Fisher Scientific Inc. (TMO), the maker of diagnostic equipment, is considering a purchase of molecular testing firm Qiagen NV (QGEN,QGENF), Bloomberg reported citing people familiar with the matter.

The Dutch company Qiagen, which is listed in New York and Frankfurt, has a market value of about $8 billion as of Wednesday's close.

There's no certainty the discussion will lead to a deal, and other bidders for Qiagen could emerge, the report said.

QGEN closed Wednesday regular trading at $35.45, up $3.19 or 9.89 percent. In the after-hours, the stock further gained $0.70 or 1.97 percent.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
eBay Inc. (EBAY) Wednesday reported a fourth-quarter profit that trumped Wall Street analysts' estimates, as did revenues. However, shares of the company slipped over 5% after the company issued a weak outlook for the first quarter. eBay's fourth-quarter profit dropped to $558 million or $0.69 per... Apple Inc. (AAPL) Wednesday reported a first-quarter profit that trumped Wall Street estimates, as the iPhone maker reported its "highest quarterly revenue ever" driven by strong demand for its iPhone 11 and 11 Pro models during the holiday season. The tech giant also issued a strong revenue outlook... New York Attorney General Letitia James has fled a lawsuit against Vyera Pharmaceuticals and two of its former CEOs, including imprisoned 'Pharma Bro' Martin Shkreli, for illegally monopolizing a life-saving drug Daraprim. The lawsuit seeks a lifetime ban on Shkreli and his business partner Kevin Mulleady working in the pharmaceutical industry.
Follow RTT
>